
Truelixir Life Science Private Limited
Manufactures and sells various pharmaceutical and chemical products for human and veterinary use.
Manufactures and sells various pharmaceutical and chemical products for human and veterinary use.
Truelixir Life Science Private Limited (TLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 May 2018 (Six years and ten months 0 days old ). Its registered office is in Aurangabad, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹25.88 Cr.
Ashok Bedse, Sunanda Bedse, Nilesh Patil, and Two other members serve as directors at the Company.
Aurangabad, Maharashtra, India
+91-XXXXXXXXXX
-
U74999MH2018PTC308831
308831
Private Limited Indian Non-Government Company
02 May 2018
30 Sep 2024
31 Mar 2024
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ashok Bedse ![]() | Director | 02-May-2018 | Current |
Sunanda Bedse ![]() | Director | 29-Apr-2019 | Current |
Nilesh Patil ![]() | Director | 02-May-2018 | Current |
Kailash Borade ![]() | Director | 02-May-2018 | Current |
Harsh Tanpure ![]() | Director | 26-Mar-2022 | Current |
Truelixir Life Science Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.38% increase. The company also saw a substantial improvement in profitability, with a 35.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.71%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Truelixir Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ashok Bedse, Sunanda Bedse and 1 more are mutual person
Kailash Borade is a mutual person
₹25.88 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
06 Apr 2024 | Others | ₹4.00 M | Open |
28 Dec 2022 | Others | ₹2.50 Cr | Open |
30 Dec 2020 | Others | ₹3.00 Cr | Open |
31 May 2019 | Others | ₹1.48 Cr | Open |
31 May 2019 | Others | ₹0.99 M | Open |
Truelixir Life Science has a workforce of 60 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Truelixir Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Truelixir Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Truelixir Life Science Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Others amounted to Rs. 0.40 Cr with Charge ID 100910832 was registered on 06 Apr 2024.
A charge with Others of Rs. 2.50 Cr registered on 28 Dec 2022 with Charge ID 100698258 was modified on 05 Apr 2024.
Truelixir Life Science Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
A charge with Others amounted to Rs. 2.50 Cr with Charge ID 100698258 was registered on 28 Dec 2022.
Harsh Arun Tanpure was appointed as a Director was appointed as a Director on 26 Mar 2022 & has been associated with this company since 2 years 11 months .
Truelixir Life Science Private Limited was incorporated on 02 May 2018.
The authorized share capital of Truelixir Life Science Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 0.10 M.
Currently 5 directors are associated with Truelixir Life Science Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Truelixir Life Science Private Limited is Plot No. C-1 Fivestar Midc Industrial Area, Shendra India, Aurangabad, Maharashtra, 431007.
The corporate identification number (CIN) of Truelixir Life Science Private Limited is U74999MH2018PTC308831 and the company number is 308831 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Truelixir Life Science Private Limited has risen by 49.38%.
As Per 2023 financial reports, 60 employees are currently employed by Truelixir Life Science Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Truelixir Life Science Private Limited has experienced an downturn of -34.71%.
As per the financial statements for fiscal Year 2023, The total open charges for Truelixir Life Science Private Limited amount to ₹ 25.88 Cr.
The most recent Balance Sheet for Truelixir Life Science Private Limited was filed with the ROC on 31 Mar 2024.
SN